Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.JNS.2021.118072 | ||||
| Año | 2021 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Objective: Currently, there are several reasons to promote worldwide the concept of multiple sclerosis care units (MSCU) for a better management of affected patients. Ideally, the MSCU should have some human and technical resources that distinguish and improve the care of affected patients; however, local, and regional aspects should be considered when recommending how these units should operate. The objective of these consensus recommendations was to review how MSCU should work in Latin America to improve long-term outcomes in MS patients. Methods: A panel of neurology experts from Latin America dedicated to the diagnosis and care of MS patients gathered virtually during 2019 and 2020 to carry out a consensus recommendation about objectives and functioning implementation of MSCU in Latin America. To achieve consensus, the methodology of “formal consensus-RAND/UCLA method” was used. Results: Recommendations focused on the objectives, human and technical resources, and the general functioning that MSCU should have in Latin America. Conclusions: The recommendations of these consensus guidelines attempt to optimize the health care and management of MS patients by setting how MSCU should work in our region.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Cristiano, Edgardo | Hombre |
Centro de Esclerosis Múltiple de Buenos Aires - Argentina
Ctr Esclerosis Multiple Buenos Aires - Argentina |
| 2 | Abad, Patricio | Hombre |
Hospital Metropolitano - Ecuador
Hosp Metropolitan Quito - Ecuador Neurol PUCE - Ecuador |
| 3 | Becker, Jefferson | Hombre |
Pontifica Universidade Católica do Rio Grande do Sul - Brasil
Pontifical Catholic Univ Rio Grande do Sul PUCRS - Brasil |
| 4 | Carra, Adriana | Mujer |
Hospital Británico de Buenos Aires - Argentina
Fundacion Favaloro - Argentina MS Sect Hosp Britan Buenos Aires - Argentina Neurociencias Fdn Favaloro INECO - Argentina |
| 5 | Correale, Jorge | Hombre |
Fundacion Para La Lucha Contra Las Enfermedades Neurologicas de La Infancia - Argentina
Dept Neurol - Argentina |
| 6 | Flores, Jose | Hombre |
Instituto Nacional de Neurología y Neurocirugía - México
Centro Neurológico ABC Santa Fé - México Inst Nacl Neurol & Neurocirug - México Ctr Neurol ABC Santa Fe - México Centro Médico ABC Santa Fe - México |
| 7 | Fruns, Manuel | Hombre |
Clínica Las Condes - Chile
|
| 8 | Garcea, Orlando | Hombre |
Hospital J.M. Ramos Mejia, Buenos Aires - Argentina
Hosp Ramos Mejia - Argentina |
| 9 | Garcia-Bonitto, Juan | Hombre |
Sistema Nacional De Salud Colombiano - Colombia
Sistema Nacl Salud Colombian - Colombia |
| 10 | Gracia, Fernando | Hombre |
Universidad Interamericana de Panamá - Panamá
Univ Interamer Panama - Panamá |
| 11 | Hamuy, Fernando | Hombre |
Hospital IMT - Paraguay
Departamento de Neurologia de Diagnóstico Codas Thompson - Paraguay Hosp IMT - Paraguay Dept Neurol Diagnost Codas Thompson - Paraguay |
| 12 | Navas, Cárlos | Hombre |
Clinica Enfermedad Desmielinizante Clinica Universitaria Colombia - Colombia
Clin Univ Colombia - Colombia |
| 13 | Patrucco, Liliana | Mujer |
Instituto Universitario del Hospital Italiano de Buenos Aires - Argentina
Hospital Británico de Buenos Aires - Argentina Hosp Italian Buenos Aires - Argentina |
| 14 | Rivera, Victor M. | Hombre |
Baylor College of Medicine - Estados Unidos
BAYLOR COLL MED - Estados Unidos |
| 15 | Velazquez, Merced | - |
Unidad de Investigación en Salud de Chihuahua - México
Unidad Invest Salud Chihuahua - México |
| 16 | Rojas, Juan Ignacio | Hombre |
Centro de Esclerosis Múltiple de Buenos Aires - Argentina
Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno - Argentina |
| 16 | Rojas, Juan I. | Hombre |
Ctr Esclerosis Multiple Buenos Aires - Argentina
Hosp Univ CEMIC - Argentina Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno - Argentina |
| Fuente |
|---|
| Novartis |
| Universitat Autònoma de Barcelona |
| Sanofi |
| Bayer |
| AstraZeneca |
| Merck |
| UCB Pharma |
| Shire |
| Roche |
| Genzyme |
| Biogen |
| Ipsen |
| Merck-Serono |
| American Academy of Neurology |
| Teva Pharmaceutical Industries |
| Universidad Aut?noma de Barcelona |
| LACTRIMS |
| CMSC |
| Horizon CME |
| Agradecimiento |
|---|
| Research was supported by a grant from LACTRIMS.EC has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis, and Roche. JIR has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. TA has received consulting fees, lecture honoraria and Travel Support from Biogen, Merck, Roche and Teva. JB has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Bayer, Biogen, Ipsen, Merck, Novartis, Roche, Sanofi, Teva. JF has received consulting fees from Biogen, Novartis, and Genzyme, as a lecturer from Merck Serono, Novartis and Biogen, and collaboration for attendance to national and international congresses from Biogen, Novartis, Merck Serono, Bayer and Gador. FG has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis, Bayer. OG has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. CN has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Stendhal, Roche, Biogen, Genzyme, Merck, Novartis, Biopas. JGB has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Stendhal, Roche, Biogen, Genzyme, Merck, Novartis. LP has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. JC has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Biogen, Genzyme, Merck, Novartis. PA has received reimbursement for developing educational presentations, educational and research grants, consultations fees and travel stipends from Bayer, Biogen, Ipsen, Merck, Novartis, Roche, Sanofi, Teva. AC has received honoraria as speaker honoraria from Biogen, Novartis, Genzyme, TEVA, Merck, Roche, Bayer and participated in advisory boards from Shire, Roche, TEVA, Merck-Serono. VR has received honoraria as speaker from the American Academy of Neurology, ACTRIMS, EMD Serono, Biogen, Stendhal Pharmaceuticals, MS American Association, Horizon CME. Travel: CMSC, LACTRIMS, MEXCTRIMS. Honorarium from Universidad Autónoma de Barcelona. MV has received honoraria speaker from Astra Zeneca, Bayer, Biogen, Bristol Myers, Chiesi, Chiltern, Genzyme, Glaxo, GTR, GW Pharma, Jansen Cilag, Medivector, Merck, Novartis, Pfizer, Roche, Sanofi, Servier, Thrombosis Research Institute and UCB Pharma. |
| Research was supported by a grant from LACTRIMS . |
| Research was supported by a grant from LACTRIMS. |